Copertina

A Practical Analysis Procedure on Generalizing Comparative Effectiveness in the Randomized Clinical Trial to the Real-world Trialeligible Population

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Jiang, Kuan, Lai, Xin-xing, Yang, Shu, Gao, Ying, Zhou, Xiao-Hua
Natura:	Preprint
Pubblicazione:	2024
Soggetti:	Applications
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
di: Mao, Guangcai, et al.
Pubblicazione: (2025)

Comparative Analysis of Augmented Reality and Virtual Reality in Biomedical Engineering Education: Acceptance and Learning Effectiveness
di: Koi‐Qi Lai, et al.
Pubblicazione: (2026)

Extending Inferences from Randomized Clinical Trials to Target Populations: A Scoping Review of Transportability Methods
di: Wang, Guanbo, et al.
Pubblicazione: (2024)

Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
di: Chen, Jie, et al.
Pubblicazione: (2024)

Analyzing Population-Level Trials as N-of-1 Trials: an Application to Gait
di: Zhou, Lin, et al.
Pubblicazione: (2022)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
di: Qiu, Sky, et al.
Pubblicazione: (2026)

Cost Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials
di: Montoya, Lina M., et al.
Pubblicazione: (2025)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
di: Sokolova, Alexandra, et al.
Pubblicazione: (2026)

Evaluating Organizational Effectiveness: A New Strategy to Leverage Multisite Randomized Trials for Valid Assessment
di: Hong, Guanglei, et al.
Pubblicazione: (2024)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
di: Yang, Peng, et al.
Pubblicazione: (2026)

Distribution-Based Sub-Population Selection (DSPS): A Method for in-Silico Reproduction of Clinical Trials Outcomes
di: Ganji, Mohammadreza, et al.
Pubblicazione: (2024)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
di: Phillips, Rachael V., et al.
Pubblicazione: (2024)

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
di: Qiu, Sky, et al.
Pubblicazione: (2025)

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
di: Gao, Yujing, et al.
Pubblicazione: (2025)

Regulatory Expectations for Bayesian Methods in Drug and Biologic Clinical Trials: A Practical Perspective on FDA's 2026 Draft Guidance
di: Ji, Yuan, et al.
Pubblicazione: (2026)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
di: Zhang, Hong, et al.
Pubblicazione: (2023)

Comparing Methods of Expert Elicitation for Treatment Effect or Borrowing Parameters in Standard and Rare Disease Clinical Trials: A Systematic Mapping Study
di: Morgan, Laura M., et al.
Pubblicazione: (2025)

Generalized Design of Basket Trials with P-value Combination Test
di: Zhou, Heng, et al.
Pubblicazione: (2024)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
di: Sunami, Hisato, et al.
Pubblicazione: (2024)

Learning Smooth Populations of Parameters with Trial Heterogeneity
di: Lee, JungHo, et al.
Pubblicazione: (2025)

Leveraging Large Language Models to Improve Precision in Randomized Controlled Trials
di: Lowe, Jaylin, et al.
Pubblicazione: (2026)

Improve Sensitivity Analysis Synthesizing Randomized Clinical Trials With Limited Overlap
di: Jiang, Kuan, et al.
Pubblicazione: (2024)

Use of Mobile Application for Improving Drug Compliance and Clinical Outcomes: A Randomized Controlled Trial
di: Pramod Kumar Mehta, et al.
Pubblicazione: (2026)

Estimating the Effective Size of European Wolf Populations
di: Joachim Mergeay, et al.
Pubblicazione: (2024)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
di: Chassat, Perrine, et al.
Pubblicazione: (2025)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
di: Lee, Jooyeon, et al.
Pubblicazione: (2025)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
di: Jobson, Deddy, et al.
Pubblicazione: (2024)

Bayesian Inference General Procedures for A Single-subject Test Study
di: Li, Jie, et al.
Pubblicazione: (2024)

The Importance of Effective Population Size in Conservation and Biodiversity Monitoring
di: Joachim Mergeay, et al.
Pubblicazione: (2026)

Multiple Imputation for Small, Extremely High Efficacy Clinical Trials with Binary Endpoints
di: Tan, Yaoyuan Vincent, et al.
Pubblicazione: (2025)

A Deep Subgrouping Framework for Precision Drug Repurposing via Emulating Clinical Trials on Real-world Patient Data
di: Lee, Seungyeon, et al.
Pubblicazione: (2024)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
di: Zhao, Yao, et al.
Pubblicazione: (2026)

Randomization Inference for Before-and-After Studies with Multiple Units: An Application to a Criminal Procedure Reform in Uruguay
di: Cattaneo, Matias D., et al.
Pubblicazione: (2024)

Assessing Vaccine Effectiveness in Observational Studies via Nested Trial Emulation
di: DeMonte, Justin B., et al.
Pubblicazione: (2024)

Dealing With Assumptions and Sampling Bias in the Estimation of Effective Population Size: A Case Study in an Amphibian Population
di: Karen Cox, et al.
Pubblicazione: (2024)

A likelihood-based sensitivity analysis for addressing publication bias in meta-analysis of diagnostic studies using exact likelihood
di: Hu, Taojun, et al.
Pubblicazione: (2024)

Population Size in Evolutionary Biology Is More Than the Effective Size
di: Joachim Mergeay
Pubblicazione: (2024)

Effects of Social Structure on Effective Population Size Change Estimates
di: Bárbara Ribeiro Parreira, et al.
Pubblicazione: (2025)

Application of Markov Chains to Multiple Sclerosis Clinical Trial Data to Estimate Disease Trajectories
di: Sthanu, Uma, et al.
Pubblicazione: (2024)

Considerations for Single-Arm Trials to Support Accelerated Approval of Oncology Drugs
di: Lu, Feinan, et al.
Pubblicazione: (2024)